CARDINAL HEALTH INC.
stock DE:CLH (FRANKFURT)

Alternative ID: US14149Y1082

Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Exchange: FRANKFURT
Sector: Healthcare
Industry: Medical Distribution
Market Cap: Large (21.87B)
Data in EUR

EPS: 3.90
Current PE: 34.41
Dividend: 1.94 / 2.5%

Hist Grade: E (20.63)
YOY Grade: E (24.87)
Debt/FCF: 1.71
ROIC: 9.0%
PEG: 5.25
PEGY: 3.79

Value Price: 13.47
MOS Price: 6.73
MOS %: -90.0%
Graham Number: 0.00
Graham MOS %: -100.0%
IRT: 26.96

Market Price

135.02

0.70 0.5%

as of Mar 20 '23

52 Week Range:

48.01 140.69

Stock Analyzer Tutorials

General Info

type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

Financial Statements

type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

Growth Grade and Financial Ratios

type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

Price Charts

type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Exchange: FRANKFURT
Sector: Healthcare
Industry: Medical Distribution
Market Cap: Large (21.87B)
Inst. Ownership: 92.64%
Insider Ownership: 0.40%
Full Time Employees: 45570

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement

Cash Flow Statement

Balance Sheet

Liquidity Ratios

Current Ratio

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name	Dec '14	Jun '15	Dec '15	Jun '16	Dec '16	Jun '17	Jun '18	Jun '19	Jun '20	Jun '21	Jun '22
Equity (BVPS)		17.31		18.74		18.39	21.10	18.33	3.65	5.17
growth rate				4.1%		-0.9%	14.7%	-13.1%	-80.1%	41.6%
Earnings BIT		2,199.00		2,420.00		2,291.00	1,985.00	1,733.00	1,772.00	1,794.00	1,664.00
growth rate				4.9%		-2.7%	-13.4%	-12.7%	2.3%	1.2%	-7.3%
Avg.PE				18.23	26.40	26.40	8.82	8.54	3,940.00	3,940.00	18.37
growth rate					44.8%	0.0%	-66.6%	-3.2%	46,035.8%	0.0%	-99.5%
ROA		4.33		4.44		3.47	0.64	3.37	-9.04	1.43
growth rate				1.3%		-11.6%	-81.6%	426.6%	-100.0%	100.0%
ROE		19.20		22.28		19.28	3.98	22.01	-91.07	34.13
growth rate				7.7%		-7.0%	-79.4%	453.0%	-100.0%	100.0%
ROIC		11.77		12.91		9.72	3.07	10.82	-30.21	8.95
growth rate				4.7%		-13.2%	-68.4%	252.4%	-100.0%	100.0%
Cur. Ratio		1.26		1.11		1.34	1.07	1.07	1.10	1.12
growth rate				-6.1%		9.9%	-20.2%	0.0%	2.8%	1.8%
Quick Ratio		0.65		0.50		0.70	0.42	0.46	0.47	0.45
growth rate				-12.3%		18.3%	-40.0%	9.5%	2.2%	-4.3%
Leverage		4.82		5.21		5.89	6.59	6.47	22.78	24.82
growth rate				4.0%		6.3%	11.9%	-1.8%	252.1%	9.0%
Balance Sheet	Dec '14	Jun '15	Dec '15	Jun '16	Dec '16	Jun '17	Jun '18	Jun '19	Jun '20	Jun '21	Jun '22
Acct.Receivable		6,576.00		7,436.00		8,101.00	7,826.00	8,460.00	8,276.00	9,110.00	10,573.00
growth rate				6.3%		4.4%	-3.4%	8.1%	-2.2%	10.1%	16.1%
Acct.Payable		14,368.00		17,306.00		17,906.00	19,677.00	21,535.00	21,374.00	23,700.00	27,128.00
growth rate				9.8%		1.7%	9.9%	9.4%	-0.8%	10.9%	14.5%
Cur.Assets		21,752.00		21,956.00		28,345.00	24,553.00	25,747.00	25,940.00	31,048.00	32,935.00
growth rate				0.5%		13.6%	-13.4%	4.9%	0.8%	19.7%	6.1%
Total Assets		30,142.00		34,122.00		40,112.00	39,951.00	40,963.00	40,766.00	44,453.00	43,878.00
growth rate				6.4%		8.4%	-0.4%	2.5%	-0.5%	9.0%	-1.3%
Cash		4,616.00		2,356.00		6,879.00	1,763.00	2,531.00	2,771.00	3,407.00	4,717.00
growth rate				-28.6%		70.9%	-74.4%	43.6%	9.5%	23.0%	38.5%
Inventory		9,211.00		10,615.00		11,301.00	12,308.00	12,822.00	13,198.00	14,594.00	15,636.00
growth rate				7.4%		3.2%	8.9%	4.2%	2.9%	10.6%	7.1%
Cur.Liabilities		17,243.00		19,701.00		21,221.00	22,893.00	24,109.00	23,615.00	27,624.00	30,550.00
growth rate				6.9%		3.8%	7.9%	5.3%	-2.1%	17.0%	10.6%
Liabilities		23,886.00		27,434.00		33,166.00	33,880.00	34,633.00	38,974.00	42,659.00	44,584.00
growth rate				7.2%		10.0%	2.2%	2.2%	12.5%	9.5%	4.5%
LT Debt		5,212.00		4,962.00		9,087.00	8,090.00	7,585.00	6,756.00	5,320.00	4,686.00
growth rate				-2.4%		35.3%	-11.0%	-6.2%	-10.9%	-21.3%	-11.9%
Equity		6,256.00		6,554.00		6,808.00	6,059.00	6,328.00	1,789.00	1,791.00	-709.00
growth rate				2.4%		1.9%	-11.0%	4.4%	-71.7%	0.1%	-100.0%
Common Shares		335.00		330.00		320.00	2,730.00	2,763.00	2,789.00	2,806.00	2,813.00
growth rate				-0.8%		-1.5%	753.1%	1.2%	0.9%	0.6%	0.3%
Cash Flow Statement	Dec '14	Jun '15	Dec '15	Jun '16	Dec '16	Jun '17	Jun '18	Jun '19	Jun '20	Jun '21	Jun '22
Capital Expenditures		300.00		465.00		387.00	384.00	328.00	375.00	400.00	387.00
growth rate				24.5%		-8.8%	-0.8%	-14.6%	14.3%	6.7%	-3.3%
Cash Dividends		460.00		512.00		577.00	581.00	577.00	569.00	573.00	559.00
growth rate				5.5%		6.2%	0.7%	-0.7%	-1.4%	0.7%	-2.4%
Cash From OA		2,540.00		2,971.00		1,184.00	2,768.00	2,722.00	1,960.00	2,429.00	3,122.00
growth rate				8.2%		-36.9%	133.8%	-1.7%	-28.0%	23.9%	28.5%
FCF per Share		5.64		7.47		1.70	7.09	7.05	5.59	4.56
growth rate				15.1%		-52.3%	317.1%	-0.6%	-20.7%	-18.4%
Sale Purchase of Stock		72.00		6.00		26.00
growth rate				-71.1%		108.2%
FCF	33.20	2,240.00	133.90	2,506.00	37.40	797.00	2,384.00	2,394.00	1,585.00	2,029.00	2,735.00
growth rate		6,647.0%	-94.0%	1,771.6%	-98.5%	2,031.0%	199.1%	0.4%	-33.8%	28.0%	34.8%
Income Statement	Dec '14	Jun '15	Dec '15	Jun '16	Dec '16	Jun '17	Jun '18	Jun '19	Jun '20	Jun '21	Jun '22
Sales		102,531.00		121,546.00		129,976.00	136,809.00	145,534.00	152,922.00	162,467.00	181,364.00
growth rate				8.9%		3.4%	5.3%	6.4%	5.1%	6.2%	11.6%
Op.Income		2,199.00		2,420.00		2,291.00	1,985.00	1,733.00	1,772.00	1,794.00	1,664.00
growth rate				4.9%		-2.7%	-13.4%	-12.7%	2.3%	1.2%	-7.3%
IBT		1,967.00		2,276.00		1,924.00	-228.00	1,751.00	-3,772.00	323.00	-769.00
growth rate				7.6%		-8.1%	-100.0%	100.0%	-100.0%	100.0%	-100.0%
Net Income		1,215.00		1,427.00		1,288.00	256.00	1,363.00	-3,696.00	611.00	-933.00
growth rate				8.4%		-5.0%	-80.1%	432.4%	-100.0%	100.0%	-100.0%
EPS		3.62		4.32		4.03	0.81	4.53	-12.61	2.08
growth rate				9.2%		-3.4%	-79.9%	459.3%	-100.0%	100.0%
Gross Profit		5,712.00		6,543.00		6,544.00	7,181.00	6,834.00	6,868.00	6,778.00	6,545.00
growth rate				7.0%		0.0%	9.7%	-4.8%	0.5%	-1.3%	-3.4%

Quarterly Statements

Item Name	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22
Earnings BIT	437.00	449.00	386.00	466.00	363.00
growth rate		2.8%	-14.0%	20.7%	-22.1%
Balance Sheet	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22
Acct.Receivable	9,110.00	9,305.00	9,406.00	10,250.00	10,573.00
growth rate		2.1%	1.1%	9.0%	3.2%
Acct.Payable	23,700.00	23,408.00	24,759.00	24,821.00	27,128.00
growth rate		-1.2%	5.8%	0.3%	9.3%
Cur.Assets	31,048.00	29,731.00	31,847.00	30,884.00	32,935.00
growth rate		-4.2%	7.1%	-3.0%	6.6%
Total Assets	44,453.00	42,993.00	43,680.00	42,111.00	43,878.00
growth rate		-3.3%	1.6%	-3.6%	4.2%
Cash	3,407.00	2,463.00	3,161.00	2,356.00	4,717.00
growth rate		-27.7%	28.3%	-25.5%	100.2%
Inventory	14,594.00	14,720.00	14,941.00	15,493.00	15,636.00
growth rate		0.9%	1.5%	3.7%	0.9%
Cur.Liabilities	27,624.00	26,499.00	27,729.00	28,715.00	30,550.00
growth rate		-4.1%	4.6%	3.6%	6.4%
Liabilities	42,659.00	41,597.00	42,678.00	42,804.00	44,584.00
growth rate		-2.5%	2.6%	0.3%	4.2%
LT Debt	5,320.00	5,353.00	5,342.00	4,751.00	4,686.00
growth rate		0.6%	-0.2%	-11.1%	-1.4%
Equity	1,791.00	1,393.00	998.00	-697.00	-709.00
growth rate		-22.2%	-28.4%	-100.0%	0.0%
Common Shares	2,806.00	2,666.00	2,721.00	2,761.00	2,813.00
growth rate		-5.0%	2.1%	1.5%	1.9%
Cash Flow Statement	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22
Capital Expenditures	126.00	67.00	74.00	82.00	164.00
growth rate		-46.8%	10.5%	10.8%	100.0%
Cash Dividends	141.00	149.00	140.00	136.00	134.00
growth rate		5.7%	-6.0%	-2.9%	-1.5%
Cash From OA	665.00	-646.00	1,195.00	-419.00	2,992.00
growth rate		-100.0%	100.0%	-100.0%	100.0%
Sale Purchase of Stock
growth rate
FCF	539.00	-713.00	1,121.00	-501.00	2,828.00
growth rate		-100.0%	100.0%	-100.0%	100.0%
Income Statement	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22
Sales	42,586.00	43,968.00	45,457.00	44,836.00	47,103.00
growth rate		3.3%	3.4%	-1.4%	5.1%
Op.Income	437.00	449.00	386.00	466.00	363.00
growth rate		2.8%	-14.0%	20.7%	-22.1%
IBT	119.00	369.00	-973.00	-137.00	-28.00
growth rate		210.1%	-100.0%	0.0%	0.0%
Net Income	116.00	271.00	49.00	-1,391.00	138.00
growth rate		133.6%	-81.9%	-100.0%	100.0%
Gross Profit	1,672.00	1,642.00	1,616.00	1,682.00	1,605.00
growth rate		-1.8%	-1.6%	4.1%	-4.6%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (20.63)

YOY Growth Grade:

E (24.87)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Dividend Yield: 2.5%
Beta: 0.78
Beta of 0.7833 suggests that the asset is less volatile than the rest of the market.
PE: 34.41
EY: 2.9%
PEG: 5.25
PEG Ratio of 5.25 suggests that stock is overpriced.
PEGY: 3.79
PEGY Ratio of 3.79 suggests that stock is overpriced.
Price/BVPS: -535.79
Price to BVPS Ratio of -535.79 suggests that stock is undervalued.

Profitability Ratios

ROE: 34.1%
Return on Equity (ROE) of 34.1% suggests that a company is doing well.
ROS: 0.9%
The value of Return on Sales depends on the business and/or industry. Usually the higher ratio the better.
ROA: -1.8%
Return on Assets (ROA). Low ratio usually means poor performance, or ineffective use of assets by management. High ratio usually means good performance.
ROI: 108.5%
Return on Investment (ROI) of 108.5% suggests that a company is doing well.
ROIC: 9.0%
Return on Invested Capital (ROIC) of 9.0% suggests that management is inefficient or it could reflect a highly capitalized, conservatively operated business with little long term debt.

Liquidity Ratios

Current Ratio: 1.08
Current Ratio of 1.08 suggests that a company may not be able to pay off bills as rapidly as it should.
Quick Ratio: 0.50
Quick Ratio of 0.50 suggests that a company does not have enough cash to cover immediate liabilities.
Cash Turnover: 76.04
Turnover Of Cash Ratio of 76.04 suggests that a company may be vulnerable to creditors. As a result it may be unable to pay wages or utility bills.
Equity Ratio: -1.6%
Equity Ratio of -1.6% suggests that a company has high financing and debt service costs, not very attractive to investors.
Debt/Equity: -6,288.3%
Debt to Equity Ratio of -6,288.3% suggests that a company is doing well.
Debt/FCF: 1.71
Debt/FCF of 1.71 suggests that a company is doing well and can pay off its long term debt within three years.

Efficiency Ratios

Avg Collection Period: 21.28
Average Collection Period of 21.28 days suggests that a company is doing well.
Inventory Turnover: 11.18
Inventory Turnover Ratio of 11.18 suggests that a company is doing well.
Cash Flow Ratio: 0.97
Cash Flow Ratio of 0.97 suggests that a company is managing it's inventory efficiently.
Profit Margin: -0.5%

Value Price

PE and EPS

	Historical	Current	Forward
PE	19.65	34.59	12.33
EPS / Growth	2.4%	3.90	6.6%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 1.0%

Estimates	Pessimistic	Moderate	Optimistic
Rate of Return	15.0%
MOS Price %	50 %
Future EPS Growth	1.0%	1.7%	1.7%
Future PE	2.00	11.79	11.79
Future EPS	4.31	4.62	4.62
Value Price MOS %	2.13 -98.4%	13.47 -90.0%	13.47 -90.0%
MOS Price	1.07	6.73	6.73
IRT	29.60	27.07	27.07

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Graham Number: 0.00
Graham MOS: -100.0%

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.